Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
The antiviral activity of UV-4 was previously demonstrated against dengue virus serotype 2 (DENV2) in multiple mouse models. Herein, step-wise minimal effective dose and therapeutic window of efficacy studies of UV-4B (UV-4 hydrochloride salt) were conducted in an antibody-dependent enhancement (ADE...
Hauptverfasser: | Warfield, KL, Plummer, EM, Sayce, AC, Alonzi, DS, Tang, W, Tyrrell, BE, Hill, ML, Caputo, AT, Killingbeck, SS, Beatty, PR, Harris, E, Iwaki, R, Kinami, K, Ide, D, Kiappes, JL, Kato, A, Buck, MD, King, K, Eddy, W, Khaliq, M, Sampath, A, Treston, AM, Dwek, RA, Enterlein, SG, Miller, JL, Zitzmann, N, Ramstedt, U, Shresta, S |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
Elsevier
2016
|
Ähnliche Einträge
Ähnliche Einträge
-
Iminosugars inhibit dengue virus production via inhibition of ER alpha-glucosidases – not glycolipid processing enzymes
von: Sayce, AC, et al.
Veröffentlicht: (2016) -
Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
von: Andrew C Sayce, et al.
Veröffentlicht: (2016-03-01) -
Targeting ER α-glucosidase I with a single-dose iminosugar treatment protects against lethal influenza and dengue virus infections
von: Warfield, K, et al.
Veröffentlicht: (2020) -
A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)
von: Kelly L. Warfield, et al.
Veröffentlicht: (2015-05-01) -
Iminosugars: promising therapeutics for influenza infection
von: Tyrrell, B, et al.
Veröffentlicht: (2016)